Oxez Turbuhaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate, the active ingredient in Oxez Turbuhaler, is a long‑acting β2‑adrenergic agonist (LABA) presented as an inhalation powder for oral inhalation use. It provides bronchodilation in chronic obstructive pulmonary disease and asthma management. GNH USA supplies Oxez Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxez Turbuhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxez Turbuhaler contains formoterol, a long‑acting bronchodilator that acts on the airway smooth‑muscle pathway to improve airflow.

- Asthma: improves control of symptoms and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): maintains bronchodilation and helps reduce breathlessness. - Exercise‑induced bronchoconstriction: provides pre‑exercise relief of airway narrowing.

Formoterol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Throat irritation - Cough - Headache - Tremor - Palpitations - Nasal congestion

Serious or Rare Side Effects: - Paradoxical bronchospasm - Severe tachycardia - Hypokalemia - Hypersensitivity reactions including anaphylaxis - Cardiovascular events such as angina - Hyperglycaemia

When using Oxez Turbuhaler, follow  g  g  t  t  d  d  d  ewline

-   t   ewline -     ewline   ewline

t  ewline  ewline  ewline  ewline \n t "  "  "  " " " " " " " " " " " " " " " " "" " " " "" " " " " " " " " " " " " " " " " ");